Endocrinology · Posterior Pituitary Disorders
The facts most likely to be tested
Central diabetes insipidus is caused by a deficiency of arginine vasopressin (ADH) production in the hypothalamus or release from the posterior pituitary.
Patients present with polyuria, nocturia, and polydipsia due to the inability to concentrate urine despite elevated serum osmolality.
The diagnosis is confirmed by a water deprivation test showing dilute urine (low urine osmolality) that fails to concentrate until the administration of exogenous desmopressin (DDAVP).
Laboratory findings reveal hypernatremia and low urine osmolality (<300 mOsm/kg) in the setting of high serum osmolality (>295 mOsm/kg).
The most common etiology of central diabetes insipidus is idiopathic or secondary to head trauma, pituitary surgery, or craniopharyngioma.
The first-line treatment for central diabetes insipidus is intranasal or oral desmopressin (DDAVP), a synthetic analog of ADH.
Distinction from nephrogenic diabetes insipidus is made by the lack of response to desmopressin in the nephrogenic form.
Vignette unlocked
A 28-year-old male presents to the clinic complaining of excessive thirst and frequent urination for the past three weeks. He reports drinking 6 liters of water daily and waking up multiple times at night to void. He underwent a transsphenoidal resection of a pituitary adenoma two months ago. Physical examination reveals dry mucous membranes but no peripheral edema. Laboratory studies show a serum sodium of 152 mEq/L and a urine osmolality of 120 mOsm/kg.
What is the most appropriate next step in management?
Administration of desmopressin (DDAVP)
The patient's history of pituitary surgery and clinical presentation of hypernatremia with dilute urine is classic for central diabetes insipidus, which is treated with desmopressin.
Full handout
High yield triage
Etiology / Epidemiology
Caused by posterior pituitary damage from trauma, neurosurgery, or craniopharyngioma.
Clinical Manifestations
Presents with polyuria and polydipsia; urine osmolality <300 mOsm/kg despite high serum osmolality.
Diagnosis
Water deprivation test confirms diagnosis; desmopressin stimulation test differentiates central from nephrogenic.
Treatment
Desmopressin is the first-line treatment; avoid fluid overload during administration.
Prognosis
Requires lifelong management; hypernatremia is the primary clinical risk if access to water is restricted.
Full handout
Epidemiology & Etiology
Central DI results from a deficiency of arginine vasopressin (AVP). Common etiologies include head trauma, pituitary surgery, or infiltrative diseases like sarcoidosis. It may also be idiopathic or familial due to genetic mutations in the prepropressophysin gene.
Pertinent Anatomy
The pathology involves the hypothalamic supraoptic and paraventricular nuclei or the posterior pituitary gland. Disruption of the hypophyseal stalk prevents the release of stored ADH into the systemic circulation.
Pathophysiology
Lack of ADH prevents water reabsorption in the renal collecting ducts via aquaporin-2 channel downregulation. This leads to the excretion of large volumes of dilute urine, causing serum hyperosmolality and hypernatremia. The body compensates via intense polydipsia to maintain fluid balance.
Clinical Manifestations
Patients present with polyuria (>3L/day) and polydipsia, specifically craving ice-cold water. Hypernatremia and dehydration occur rapidly if the patient is unable to drink. Physical exam may reveal signs of volume depletion, but hypertension is rare.
Diagnosis
The water deprivation test is the gold standard, showing continued dilute urine despite dehydration. A desmopressin stimulation test is diagnostic for central DI if urine osmolality increases by >50%. Serum osmolality is typically >295 mOsm/kg.
Treatment
Desmopressin (DDAVP) is the first-line synthetic analog. Hyponatremia is a major risk if the patient continues to drink excessive water while on medication. For mild cases, thiazide diuretics or carbamazepine may be used as adjuncts.
Prognosis
Prognosis is excellent with proper hormone replacement. Serum sodium must be monitored closely to prevent life-threatening fluctuations. Patients must have unrestricted access to water to avoid severe dehydration.
Differential Diagnosis
Nephrogenic DI: No response to desmopressin
Primary Polydipsia: Low serum osmolality
Diabetes Mellitus: Presence of glucosuria
Osmotic Diuresis: High urine osmolality
Hypercalcemia: Often causes nephrogenic DI